UriFlexThis page contains information on UriFlex for veterinary use.
The information provided typically includes the following:
- UriFlex Indications
- Warnings and cautions for UriFlex
- Direction and dosage information for UriFlex
UriFlexThis treatment applies to the following species:
50 mg Chewable Tablets
FOR USE IN DOGS ONLY
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
UriFlex-PT chewable tablets contain 50 mg of phenylpropanolamine hydrochloride. Phenylpropanolamine is an α-adrenergic agonist which has been shown to increase urethral sphincter pressure in dogs. Loss of urethral sphincter tone and decreased sphincter pressure is associated with urinary incontinence in ovariohysterectomized or anestrous dogs.
UriFlex-PT is indicated for the control of urinary incontinence caused by urethral sphincter incompetence in female dogs.
Dosage & Administration:
The recommended dose of UriFlex-PT is 3 mg per kg body weight per day, divided into two or three equal oral doses. Some patients may achieve an adequate clinical response with a lower dose. Dosage may be rounded to the nearest 12.5 mg for practical dosing.
Not for human use. Keep this and all drugs out of reach of children. UriFlex-PT should be avoided or used cautiously in dogs with glaucoma, cardiac disease, hypertension, renal insufficiency, and diabetes mellitus.
UriFlex-PT should not be administered with other sympathomimetic drugs or tricyclic antidepressants, nor within two weeks of a monoamine oxidase inhibitor because of the risk of acute hypertension. UriFlex-PT may increase the risk of cardiac arrhythmias from halogenated gaseous anesthetics. Possible side-effects include restlessness, irritability, tachycardia, hypertension, and anorexia. It may take several days for the full benefit of the drug to be seen. Missed doses may negate the desired effect.
Adverse reactions related to administration of UriFlex-PT may include restlessness, irritability, tachycardia, hypertension, urinary retention and anorexia.
Store between 2°-30°C (36°-86°F). Keep container tightly closed.
UriFlex-PT tablets are available in 60 count and 180 count bottles.
FOR ANIMAL USE ONLY
Manufactured for BUTLER ANIMAL HEALTH SUPPLY, Dublin, OH 43017
NAC No.: 10822342
400 METRO PLACE NORTH, DUBLIN, OH, 43017-7545
|Every effort has been made to ensure the accuracy of the UriFlex information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06